Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation.
OBJECTIVE
To describe the thromboelastography (TEG) "reference" values within a population of liver transplant (LT) candidates that underline the differences from healthy patients.


METHODS
Between 2000 and 2013, 261 liver transplant patients with a model for end-stage liver disease (MELD) score between 15 and 40 were studied. In particular the adult patients (aged 18-70 years) underwent to a first LT with a MELD score between 15 and 40 were included, while all patients with acute liver failure, congenital bleeding disorders, and anticoagulant and/or antiplatelet drug use were excluded. In this population of cirrhotic patients, preoperative haematological and coagulation laboratory tests were collected, and the pretransplant thromboelastographic parameters were studied and compared with the parameters measured in a previously studied population of 40 healthy subjects. The basal TEG parameters analysed in the cirrhotic population of liver candidates were as follows: Reaction time (r), coagulation time (k), Angle-Rate of polymerization of clot (α Angle), Maximum strenght of clot (MA), Amplitudes of the TEG tracing at 30 min and 60 min after MA is measured (A30 and A60), and Fibrinolysis at 30 and 60 min after MA (Ly30 and Ly60). The possible correlation between the distribution of the reference range and the gender, age, MELD score (higher or lower than 20) and indications for transplantation (liver pathology) were also investigated. In particular, a MELD cut-off value of 20 was chosen to verify the possible correlation between the thromboelastographic reference range and MELD score.


RESULTS
Most of the TEG reference values from patients with end-stage liver disease were significantly different from those measured in the healthy population and were outside the suggested normal ranges in up to 79.3% of subjects. Wide differences were found among all TEG variables, including r (41.5% of the values), k (48.6%), α (43.7%), MA (79.3%), A30 (74.4%) and A60 (80.9%), indicating a prevailing trend to hypocoagulability. The differences between the mean TEG values obtained from healthy subjects and the cirrhotic population were statistically significant for r (P = 0.039), k (P < 0.001), MA (P < 0.001), A30 (P < 0.001), A60 (P < 0.001) and Ly60 (P = 0.038), indicating slower and less stable clot formation in the cirrhotic patients. In the cirrhotic population, 9.5% of patients had an r value shorter than normal, indicating a tendency for faster clot formation. Within the cirrhotic patient population, gender, age and the presence of hepatocellular carcinoma or alcoholic cirrhosis were not significantly associated with greater clot firmness or enhanced whole blood clot formation, whereas greater clot strength was associated with a MELD score < 20, hepatitis C virus and cholestatic-related cirrhosis (P < 0.001; P = 0.013; P < 0.001).


CONCLUSIONS
The range and distribution of TEG values in cirrhotic patients differ from those of healthy subjects, suggesting that a specific thromboelastographic reference range is required for liver transplant candidates.
Lesley De Pietri, Division of Anaesthesiology and Intensive Care Unit, Department of Cardiology, Thoracic and Vascular Surgery, Critical Care Medicine, Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy.
Lesley
L
De Pietri
Lesley De Pietri, Division of Anaesthesiology and Intensive Care Unit, Department of Cardiology, Thoracic and Vascular Surgery, Critical Care Medicine, Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy.
Marcello
M
Bianchini
Lesley De Pietri, Division of Anaesthesiology and Intensive Care Unit, Department of Cardiology, Thoracic and Vascular Surgery, Critical Care Medicine, Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy.
Gianluca
G
Rompianesi
Lesley De Pietri, Division of Anaesthesiology and Intensive Care Unit, Department of Cardiology, Thoracic and Vascular Surgery, Critical Care Medicine, Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy.
Elisabetta
E
Bertellini
Lesley De Pietri, Division of Anaesthesiology and Intensive Care Unit, Department of Cardiology, Thoracic and Vascular Surgery, Critical Care Medicine, Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy.
Bruno
B
Begliomini
Blood coagulation disorder; Liver cirrhosis; Liver transplantation; Reference values; Thromboelastography
Am J Gastroenterol. 2006 Jul;101(7):1524-8; quiz 1680
16863556
Blood Coagul Fibrinolysis. 2008 Dec;19(8):777-83
19002044
Hepatology. 2016 Feb;63(2):566-73
26340411
Am J Transplant. 2005 Feb;5(2):307-13
15643990
J Investig Med. 2001 Sep;49(5):407-12
11523696
N Engl J Med. 2011 Jul 14;365(2):147-56
21751907
Transplant Proc. 2012 Jul-Aug;44(6):1523-5
22841202
Hepatology. 2006 Oct;44(4):1039-46
17006940
PLoS One. 2014 Jun 06;9(6):e98782
24905210
Braz J Med Biol Res. 2009 Dec;42(12):1210-7
19882085
Curr Opin Crit Care. 2013 Apr;19(2):142-8
23400090
Semin Thromb Hemost. 2010 Oct;36(7):712-22
20978992
Liver Transpl. 2008 Jun;14(6):855-60
18508379
Anesth Analg. 2004 Aug;99(2):449-54, table of contents
15271723
Liver Int. 2012 Jul;32(6):1027; author reply 1028
22212705
Blood. 1983 Jun;61(6):1196-202
6839020
Blood Coagul Fibrinolysis. 2005 Jun;16(4):301-10
15870552
J Hepatol. 2007 Apr;46(4):727-33
17316874
J Hepatol. 2011 Dec;55(6):1415-27
21718668
J Hepatol. 2012 Oct;57(4):780-6
22735303
Transpl Int. 2013 Apr;26(4):435-42
23356587
Gastroenterol Hepatol (N Y). 2012 Aug;8(8):513-20
23293564
Best Pract Res Clin Gastroenterol. 2013 Aug;27(4):553-63
24090942
Blood Transfus. 2013 Jan;11(1):32-6
23058863
J Thromb Haemost. 2003 Jul;1(7):1504-14
12871286
Platelets. 2006 Dec;17(8):509-18
17127479
Thromb Res. 1998 Sep 1;91(5):241-8
9755837
Zhonghua Yi Xue Za Zhi. 2011 Apr 12;91(14):980-3
21609551
Liver Transpl. 2013 Aug;19(8):852-61
23696318
Liver Transpl. 2012 Oct;18(10):1254-8
22730210
Anaesthesia. 2010 Jan;65(1):44-9
19889111
Anesth Analg. 1985 Sep;64(9):888-96
3896028
Arq Bras Cir Dig. 2013 Nov-Dec;26(4):324-7
24510043
Hepatology. 2006 Jul;44(1):53-61
16799972
Haemophilia. 2011 May;17(3):532-7
21323795
Br J Haematol. 1976 Nov;34(3):427-39
186092
Hamostaseologie. 2006 Aug;26(3 Suppl 1):S64-76
16953295
Blood Coagul Fibrinolysis. 2001 Oct;12(7):555-61
11685044
Eur J Anaesthesiol. 2013 Jun;30(6):270-382
23656742
Hepatogastroenterology. 2001 May-Jun;48(39):818-22
11462931
Dig Dis Sci. 2004 May;49(5):854-8
15259509
Hepatology. 2006 Aug;44(2):440-5
16871542
J Trauma Acute Care Surg. 2013 Dec;75(6):947-53
24256665
Clin Liver Dis. 2011 Nov;15(4):685-98
22032523
J Hepatol. 1997 Mar;26(3):554-9
9075662
Thromb Haemost. 1994 Jun;71(6):727-30
7605424
Blood. 2010 Aug 12;116(6):878-85
20400681
Transplant Proc. 2012 Nov;44(9):2857-60
23146542
Eur J Intern Med. 2010 Apr;21(2):65-9
20206872
J Hepatol. 2002 Nov;37(5):548-55
12399218
Digestion. 2013;88(3):135-44
24008288
Anesth Analg. 1999 Feb;88(2):312-9
9972747
Dig Dis Sci. 2008 Nov;53(11):3012-7
18443906
Hepatology. 2005 Mar;41(3):553-8
15726661
Anesth Analg. 2000 Nov;91(5):1279-81
11049922